Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Current treatments and trials in malignant pleural mesothelioma.

Bibby AC, Maskell NA.

Clin Respir J. 2018 Jul;12(7):2161-2169. doi: 10.1111/crj.12938.

PMID:
30129116
2.

ERS/EACTS statement on the management of malignant pleural effusions.

Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Maskell NA, Cardillo G.

Eur J Cardiothorac Surg. 2018 Jul 27. doi: 10.1093/ejcts/ezy258. [Epub ahead of print] No abstract available.

PMID:
30060030
3.

ERS/EACTS statement on the management of malignant pleural effusions.

Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800349. doi: 10.1183/13993003.00349-2018. Print 2018 Jul.

PMID:
30054348
4.

Are intra-pleural bacterial products associated with longer survival in adults with malignant pleural effusions? A systematic review.

Bibby AC, Walker S, Maskell NA.

Lung Cancer. 2018 Aug;122:249-256. doi: 10.1016/j.lungcan.2018.06.002. Epub 2018 Jun 11.

5.

Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis.

Walker SP, Bibby AC, Halford P, Stadon L, White P, Maskell NA.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800864. doi: 10.1183/13993003.00864-2018. Print 2018 Sep.

PMID:
30002105
6.

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.

Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, Mustafa RA, Bishop LJ, Ahmed L, West A, Holme J, Evison M, Munavvar M, Sivasothy P, Herre J, Cooper D, Roberts M, Guhan A, Hooper C, Walters J, Saba TS, Chakrabarti B, Gunatilake S, Psallidas I, Walker SP, Bibby AC, Smith S, Stadon LJ, Zahan-Evans NJ, Lee YCG, Harvey JE, Rahman NM, Miller RF, Maskell NA.

N Engl J Med. 2018 Apr 5;378(14):1313-1322. doi: 10.1056/NEJMoa1716883.

7.

Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.

Bibby AC, Torgerson DJ, Leach S, Lewis-White H, Maskell NA.

Trials. 2018 Jan 8;19(1):18. doi: 10.1186/s13063-017-2432-3.

8.

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study.

Bibby AC, De Fonseka D, Morley AJ, Keenan E, Addeo A, Smith S, Edey AJ, Maskell NA.

BMC Palliat Care. 2017 Dec 8;16(1):71. doi: 10.1186/s12904-017-0255-3.

9.

Benign pleural schwannoma presenting with a large, blood-stained pleural effusion.

Bibby AC, Daly R, Internullo E, Edey AJ, Maskell NA.

Thorax. 2018 May;73(5):497-498. doi: 10.1136/thoraxjnl-2017-211102. Epub 2017 Nov 9. No abstract available.

PMID:
29123017
10.

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.

Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I.

Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016. Review.

11.

Current best practice in the evaluation and management of malignant pleural effusions.

Walker S, Bibby AC, Maskell NA.

Ther Adv Respir Dis. 2017 Feb;11(2):105-114. doi: 10.1177/1753465816671697. Epub 2016 Oct 24. Review.

12.

What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UK.

Bibby AC, Williams K, Smith S, Bhatt N, Maskell NA.

BMJ Open. 2016 Sep 8;6(9):e012092. doi: 10.1136/bmjopen-2016-012092.

13.

Pleural biopsies in undiagnosed pleural effusions; Abrams vs image-guided vs thoracoscopic biopsies.

Bibby AC, Maskell NA.

Curr Opin Pulm Med. 2016 Jul;22(4):392-8. doi: 10.1097/MCP.0000000000000258. Review.

PMID:
27055071
14.

Medical and oncological management of malignant mesothelioma.

Bibby AC, Gibbs L, Braybrooke JP.

Br J Hosp Med (Lond). 2015 Jul;76(7):384-9. doi: 10.12968/hmed.2015.76.7.384. Review.

PMID:
26140556
15.

Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.

Bibby AC, Clive AO, Slade GC, Morley AJ, Fallon J, Psallidas I, Pepperell JCT, Slade MG, Stanton AE, Rahman NM, Maskell NA.

Chest. 2015 Jul;148(1):235-241. doi: 10.1378/chest.14-2199.

PMID:
25429399
16.

Nutritional management in chyle leaks and chylous effusions.

Bibby AC, Maskell NA.

Br J Community Nurs. 2014 Oct;Suppl Nutrition:S6-8. doi: 10.12968/bjcn.2014.19.Sup11.S6.

PMID:
25381927
17.

Pleural procedures: intercostal chest drains and indwelling pleural catheters.

Bibby AC, Maskell NA.

Br J Hosp Med (Lond). 2011 Jun;72(6):331-5.

PMID:
21727812
18.

Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?

Bibby AC, Farrell A, Cummins M, Erlewyn-Lajeunesse M.

Arch Dis Child. 2008 Apr;93(4):354-5. doi: 10.1136/adc.2007.132340. No abstract available.

PMID:
18356391
19.

Academia needs to acknowledge the needs of trainees.

Bibby AC.

BMJ. 2007 Mar 10;334(7592):491. No abstract available.

21.

Supplemental Content

Loading ...
Support Center